Literature DB >> 19124006

HSV-2 induces TLRs and NF-kappaB-dependent cytokines in cervical epithelial cells.

Hui Li1, Xiaoling Li, Yun Wei, Yun Tan, Xuefeng Liu, Xinxing Wu.   

Abstract

Herpes simplex virus type 2 (HSV-2) is one of the most common sexually transmitted pathogens worldwide. The host immune response induced by viral infection is cell-type specific. Little is known about the innate immune response to this virus in its natural host cells. In this study, we established an in vitro HSV-2 infection model with human cervical epithelial (HCE) cells. The viral infection was sufficient to induce expression of Toll-like receptors (TLRs), and Western blot and reporter assays suggest that HSV-2 infection leads to dramatic activation of the NF-kappaB signaling pathway. More importantly, our data provide direct evidence that the activation of NF-kappaB is required for the production of both IL-6 and IFN-beta induced by HSV-2 in HCE cells. Taken together, our results suggest the potential contributions of TLRs and a critical role of NF-kappaB in the innate immune response to HSV-2 in HCE cells.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19124006     DOI: 10.1016/j.bbrc.2008.12.150

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  13 in total

1.  Plasma cytokine levels and risk of HIV type 1 (HIV-1) transmission and acquisition: a nested case-control study among HIV-1-serodiscordant couples.

Authors:  Erin M Kahle; Michael Bolton; James P Hughes; Deborah Donnell; Connie Celum; Jairam R Lingappa; Allan Ronald; Craig R Cohen; Guy de Bruyn; Youyi Fong; Elly Katabira; M Juliana McElrath; Jared M Baeten
Journal:  J Infect Dis       Date:  2014-11-10       Impact factor: 5.226

2.  Inhibitory activity and mechanism of silver nanoparticles against herpes simplex virus type 1.

Authors:  Xuanhe Pan; Yapeng Zhang; Yiming Zhao; Siqi Yao; Chaxiang Guan; Linqian Wang; Liyu Chen
Journal:  Arch Virol       Date:  2022-06-01       Impact factor: 2.685

3.  Downregulation of cellular c-Jun N-terminal protein kinase and NF-κB activation by berberine may result in inhibition of herpes simplex virus replication.

Authors:  Siwei Song; Min Qiu; Ying Chu; Deyan Chen; Xiaohui Wang; Airong Su; Zhiwei Wu
Journal:  Antimicrob Agents Chemother       Date:  2014-06-09       Impact factor: 5.191

4.  Antiviral activity of trappin-2 and elafin in vitro and in vivo against genital herpes.

Authors:  Anna G Drannik; Kakon Nag; Jean-Michel Sallenave; Kenneth L Rosenthal
Journal:  J Virol       Date:  2013-05-01       Impact factor: 5.103

5.  Herpes simplex virus type 2 triggers reactivation of Kaposi's sarcoma-associated herpesvirus from latency and collaborates with HIV-1 Tat.

Authors:  Qiao Tang; Di Qin; Zhigang Lv; Xiaolei Zhu; Xinting Ma; Qin Yan; Yi Zeng; Yuanyuan Guo; Ninghan Feng; Chun Lu
Journal:  PLoS One       Date:  2012-02-09       Impact factor: 3.240

Review 6.  Toll-like receptor sensing of human herpesvirus infection.

Authors:  John A West; Sean M Gregory; Blossom Damania
Journal:  Front Cell Infect Microbiol       Date:  2012-10-08       Impact factor: 5.293

7.  HSV-2 increases TLR4-dependent phosphorylated IRFs and IFN-β induction in cervical epithelial cells.

Authors:  Hongya Liu; Kai Chen; Wenqiang Feng; Juanjuan Guo; Hui Li
Journal:  PLoS One       Date:  2014-04-10       Impact factor: 3.240

8.  TLR4-MyD88/Mal-NF-kB axis is involved in infection of HSV-2 in human cervical epithelial cells.

Authors:  Hongya Liu; Kai Chen; Wenqiang Feng; Xinxing Wu; Hui Li
Journal:  PLoS One       Date:  2013-11-20       Impact factor: 3.240

9.  Herpes simplex virus type-2 stimulates HIV-1 replication in cervical tissues: implications for HIV-1 transmission and efficacy of anti-HIV-1 microbicides.

Authors:  C Rollenhagen; M J Lathrop; S L Macura; G F Doncel; S N Asin
Journal:  Mucosal Immunol       Date:  2014-02-05       Impact factor: 7.313

10.  Differential expression of mRNA and miRNA in guinea pigs following infection with HSV2v.

Authors:  Lin Kuang; Yihui Deng; Xiaodan Liu; Zhixiang Zou; Lan Mi
Journal:  Exp Ther Med       Date:  2017-07-19       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.